Hims & Hers Health Inc
NYSE:HIMS
Hims & Hers Health Inc
NYSE:HIMS
Price:
20.405 USD
4.21%
Updated:
May 30, 2024
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA
1 908.6
Current
-19.8
Median
12.8
Industry
Higher
than median
Higher
than industry value
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
EV/EBITDA
=1 908.6
Enterprise Value
/
4B
EBITDA
2.1m
All Countries
| Market Cap | EV/EBITDA | ||||
|---|---|---|---|---|---|
| US |
|
Hims & Hers Health Inc
NYSE:HIMS
|
4.2B USD | 1 908.6 | |
| US |
|
Cigna Corp
NYSE:CI
|
94.6B USD | 9.5 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
87.4B EUR | 9.5 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
67.2B USD | 8.4 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
16.2B EUR | 10.4 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
16.2B USD | 11.5 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
15.3B USD | 10.9 | |
| US |
|
DaVita Inc
NYSE:DVA
|
12.9B USD | 8.6 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.3B EUR | 6.5 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
11.2B EUR | 6.4 | |
| US |
|
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | -23.3 |
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBITDA
29.9
2-Years Forward
EV/EBITDA
21.4
3-Years Forward
EV/EBITDA
15.4
You don't have any saved screeners yet
